ArticleEuropean journal of gastroenterology & hepatology2019

No difference between direct-acting antivirals for hepatitis C in hepatocellular carcinoma risk.

Elijah J Mun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.